Literature DB >> 11837833

Calcaneal osteotomy and transfer of the tendon of flexor digitorum longus for stage-II dysfunction of tibialis posterior. Three- to five-year results.

J T Wacker1, M S Hennessy, T S Saxby.   

Abstract

The treatment of acquired flat foot secondary to dysfunction of the posterior tibial tendon (PTT) of stage II, as classified by Johnson and Strom, remains controversial. Joint sparing and soft-tissue reconstructive procedures give good early results, but few studies describe those in the medium-term. We studied prospectively the outcome of surgery in 51 patients with classical stage-II dysfunction of the PTT treated by a medial displacement calcaneal osteotomy and transfer of the tendon of flexor digitorum longus. We reviewed 44 patients with a mean follow-up of 51 months (38 to 62). The mean American Orthopaedic Foot and Ankle Society ankle/hindfoot rating scale improved from 48.8 before operation to 88.5 at follow-up. The operation failed in two patients who later had a calcaneocuboid fusion. The outcome in 43 patients was rated as good to excellent for pain and function, and in 36 good to excellent for alignment. There were no poor results.

Entities:  

Mesh:

Year:  2002        PMID: 11837833     DOI: 10.1302/0301-620x.84b1.11847

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  14 in total

Review 1.  Tibialis posterior dysfunction: a common and treatable cause of adult acquired flatfoot.

Authors:  Julie Kohls-Gatzoulis; John C Angel; Dishan Singh; Fares Haddad; Julian Livingstone; Greg Berry
Journal:  BMJ       Date:  2004-12-04

2.  Flexor digitorum longus transfer and medial displacement calcaneal osteotomy for the treatment of stage II posterior tibial tendon dysfunction: kinematic and functional results of fifty one feet.

Authors:  Reinhard Schuh; Florian Gruber; Axel Wanivenhaus; Nikolaus Hartig; Reinhard Windhager; Hans-Joerg Trnka
Journal:  Int Orthop       Date:  2013-08-22       Impact factor: 3.075

3.  Return to sport activities after medial displacement calcaneal osteotomy and flexor digitorum longus transfer.

Authors:  F G Usuelli; C A Di Silvestri; R D'Ambrosi; C Maccario; E W Tan
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-10-15       Impact factor: 4.342

4.  Surgical treatment of stage II posterior tibialis tendon dysfunction: ten-year clinical and radiographic results.

Authors:  Alberto Ruffilli; Francesco Traina; Sandro Giannini; Roberto Buda; Fabrizio Perna; Cesare Faldini
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-07-11

5.  Optimal Position of the Heel Following Reconstruction of the Stage II Adult-Acquired Flatfoot Deformity.

Authors:  Matthew S Conti; Scott J Ellis; Jeremy Y Chan; Huong T Do; Jonathan T Deland
Journal:  Foot Ankle Int       Date:  2015-05-06       Impact factor: 2.827

6.  Correction and prevention of deformity in type II tibialis posterior dysfunction.

Authors:  Stephen Parsons; Soulat Naim; Paula J Richards; Donald McBride
Journal:  Clin Orthop Relat Res       Date:  2010-04       Impact factor: 4.176

7.  Changes in matrix protein biochemistry and the expression of mRNA encoding matrix proteins and metalloproteinases in posterior tibialis tendinopathy.

Authors:  Anthony N Corps; Andrew H N Robinson; Rebecca L Harrall; Nicholas C Avery; Valerie A Curry; Brian L Hazleman; Graham P Riley
Journal:  Ann Rheum Dis       Date:  2012-01-12       Impact factor: 19.103

8.  Posterior tibial tendon dysfunction: an overlooked cause of foot deformity.

Authors:  Preet Singh Bubra; Geffrey Keighley; Shruti Rateesh; David Carmody
Journal:  J Family Med Prim Care       Date:  2015 Jan-Mar

Review 9.  Evaluation and Treatment of Posterior Tibialis Tendon Insufficiency in the Elderly Patients.

Authors:  Tochukwu C Ikpeze; James D Brodell; Raymond E Chen; Irvin Oh
Journal:  Geriatr Orthop Surg Rehabil       Date:  2019-01-24

Review 10.  Reported selection criteria for adult acquired flatfoot deformity and posterior tibial tendon dysfunction: Are they one and the same? A systematic review.

Authors:  Megan H Ross; Michelle D Smith; Bill Vicenzino
Journal:  PLoS One       Date:  2017-12-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.